To evaluate the prognostic value of selected PARP gene expression levels in CRC, we collected paired tumor and adjacent normal tissue samples from rectal cancer patients both before and after their neoadjuvant chemo-radiotherapy (CRT) course (Fig. 5A). Here, PARP1 is linked to colorectal carcinoma.